| Brand Name | Rx Aushadhi |
|---|---|
| Industry | Healthcare |
| Business Category | Pharmacies |
| Founded Year | 2018 |
| Franchise Started Year | 2023 |
| Headquarters | Indore, Madhya Pradesh, India |
| Total Franchise Outlets | 1–10 |
| Estimated Investment | INR 10–20 Lakh |
| Franchise Fee | INR 2,00,000 |
| Royalty Fee | 25% (typically covers ongoing brand support and system usage) |
| Space Requirement | 300–400 sq.ft |
| Expected Payback Period | 2 years |
Rx Aushadhi is an online and offline pharmacy network offering prescription medicines, over-the-counter products, and healthcare services. The brand operates within the healthcare and retail pharmacy segment, targeting consumers seeking convenient access to pharmaceutical products, wellness items, and trusted medical guidance. Its broader category aligns with pharmacy franchise opportunities focusing on community health and retail medicine services.
Franchise outlets provide direct access to medicines and healthcare products. Customers can purchase in-store or via digital platforms. Revenue is generated through sales of prescription medicines, OTC drugs, health supplements, and wellness products. Daily operations include inventory management, patient consultation, order fulfillment, and customer service, following regulatory and safety standards for pharmacies.
| Prescription Medicines | Tablets, syrups, injections, and specialty drugs |
|---|---|
| Over-the-Counter Products | Pain relief, vitamins, supplements, and first-aid items |
| Wellness and Personal Care | Hygiene products, skincare, and health supplements |
| Online Ordering & Delivery | Integrated digital platform for customer convenience |
Franchise partners operate Rx Aushadhi stores under the brand’s guidelines. Responsibilities include:
The franchisor provides training, marketing support, inventory guidance, and operational oversight.
| Estimated Investment | INR 10–20 Lakh |
|---|---|
| Franchise Fee | INR 2,00,000 |
| Setup Costs | Store interiors, shelves, storage, inventory, POS system |
| Royalty Fee | 25%, covering brand support, technology, and operational guidance |
| Space Requirement | 300–400 sq.ft |
|---|---|
| Location Preferences | High-footfall areas such as shopping centers, residential complexes, or medical hubs |
| Equipment Needs | Storage racks, display units, refrigeration for medicines, POS systems |
| Staffing Considerations | Pharmacists, store assistants, and inventory managers |
Revenue comes from medicine and wellness product sales. Profit drivers include:
The expected payback period is approximately 2 years, reflecting regulated pharmacy margins and growth potential.
| Founded | 2018 |
|---|---|
| Franchising Commenced | 2023 |
| Franchise Network Size | Currently 1–10 outlets |
| Geographic Presence | Indore and surrounding regions in Madhya Pradesh |
| Expansion Goals | Targeting 100+ stores by 2025 to expand local healthcare access |
| Apollo Pharmacy | Retail pharmacy chain across India |
|---|---|
| MedPlus | Pharmacy and healthcare retail stores |
| 1mg Stores | Online and offline pharmacy solutions |
| Netmeds Franchise | Health and wellness retail network |
| Guardian Pharmacy | Healthcare product and OTC retailer |
This profile provides a factual, investor-focused overview of the Rx Aushadhi franchise opportunity, emphasizing operational, financial, and strategic details.
Investment ranges from INR 10–20 Lakh, including store setup, initial inventory, and franchise fee.
Franchisees manage retail pharmacy outlets offering prescription and OTC medicines, personal care items, and wellness products. Operations include inventory, sales, and customer service.
Stores need 300–400 sq.ft, suitable for urban retail locations or near healthcare hubs.
The expected payback period is 2 years, depending on sales and customer volume.
Prospective franchisees can contact Rx Aushadhi directly to receive application guidance, training, and operational support for store launch. ### 14. Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.